Cabozantinib Market Expands as Targeted Oncology Therapies Drive Demand for Advanced Cancer Treatments https://dataintelo.com/report/global-cabozantinib-market The global Cabozantinib Market is witnessing significant growth driven by the increasing global burden of cancer and rising adoption of targeted therapies in oncology. Cabozantinib, a tyrosine kinase inhibitor, is gaining momentum as a promising treatment for various cancers, including renal cell carcinoma, hepatocellular carcinoma, and medullary thyroid cancer. According to a recent report by Dataintelo, the Cabozantinib Market is projected to exceed USD 3.1 billion by 2032, growing at a CAGR of 7.6% from 2024 to 2032. The market is being shaped by ongoing clinical research, increasing healthcare awareness, and rising access to oncology treatments in emerging economies.